CNS Pharmaceuticals, Inc. (CNSP)

Price & Market Data

Price: $6.25

Daily Change: -$0.51 / 8.16%

Daily Range: $6.12 - $7.38

Market Cap: $4,966,068

Daily Volume: 66,855

Performance Metrics

1 Week: -14.41%

1 Month: 143.8%

3 Months: 49.63%

6 Months: -6.85%

1 Year: -57.85%

YTD: 16.57%

About CNS Pharmaceuticals, Inc. (CNSP)

Understand CNS Pharmaceuticals, Inc. (CNSP)'s current market standing. Current price: 6.25, daily change: -$0.51 / 8.16%. Market cap: 4,966,068. Detailed performance for all periods.

Company Details

Employees: 8

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.

Selected stocks

Lexicon Pharmaceuticals, Inc. (LXRX)

ChipMOS TECHNOLOGIES INC. (IMOS)

Galectin Therapeutics Inc. (GALT)

Rent the Runway, Inc. (RENT)

Sun Communities, Inc. (SUI)